You don't have javascript enabled. Good luck with that.
Skip to content
For US Healthcare Professionals Only.

Surveyed Dermatology Providers Believe

CHRONIC HAND ECZEMA IS WIDELY MISUNDERSTOOD AND INADEQUATELY MANAGED1

Actor portrayal. For illustrative purposes only.

A 2025 survey of nearly 200 combined dermatologists, nurse practitioners, and physician assistants provided a timely perspective into their experiences treating moderate-to-severe chronic hand eczema (CHE). Survey results shed light on the perceived challenges of treating CHE and its effects on patients’ well-being.1

~2 OUT OF 3 PROVIDERS CONSIDER MODERATE-TO-SEVERE CHE MORE FRUSTRATING TO MANAGE VS PSORIASIS1

65%

strongly agreed there’s a lack of education and understanding of CHE as a condition separate from atopic dermatitis1*

>50%

strongly agreed there’s a lack of options available to effectively treat moderate-to-severe CHE1*

4

annual office visits are typical for patients with CHE1

37%

of CHE patients scheduled visits in the previous 6 months due to treatment ineffectiveness1

3

medications are used by a typical patient to treat CHE1

SIGN UP TO RECEIVE UPDATES ON CHE

HCPs SAY CHE PLACES A SIGNIFICANT BURDEN ON PATIENTS' WORK AND HOME LIFE1

CHE makes my patients feel self-conscious1*

Bar showing 92% of providers strongly agree that CHE makes patients feel self-conscious.

CHE impacts my patients’ ability to work1*

Bar showing 91% of providers strongly agree that CHE affects patients’ ability to work.

CHE impacts my patients’ relationships with family and friends1*

Bar showing 72% of providers strongly agree that CHE impacts patients’ relationships with family and friends.

CHE impacts my patients’ desire to be intimate with a significant other1*

Bar showing 68% of providers strongly agree that CHE affects patients’ desire for intimacy with a significant other.

*HCPs responded on a 7-point scale, with 5-7 representing "strongly agree."

HCPs believe there is a lack of education and understanding of CHE as a condition separate from atopic dermatitis.1
LEARN MORE ABOUT CHE DIAGNOSIS AND CURRENT TREATMENT APPROACHES HERE.

DIAGNOSIS & TREATMENT

Reference: 1. Data on File. LEO Pharma Inc.

Survey participants included 100 dermatologists and 92 nurse practitioners or physician assistants. Survey responses are weighted according to regional representation. Findings reflect the opinion of these respondents only.